Key result
Male gender is linked to ~30% higher mortality after retroperitoneal liposarcoma resection versus females.
Why the study?
Current evidence regarding gender differences in prognosis after primary resection of retroperitoneal liposarcoma is scarce.
Does male gender worsen prognosis after primary resection of retroperitoneal liposarcoma compared to female gender?
Cohort (n=2,108)
Yes
Does male gender worsen prognosis after primary resection of retroperitoneal liposarcoma compared to female gender?
Male gender is associated with worse overall survival after primary resection of retroperitoneal liposarcoma compared to female gender, particularly in patients with low-grade tumors or non-radical resection.
Answers are grounded in this paper and cite their sources.
No change to resection strategy warranted; leaves open validation of sex as prognostic factor in prospective sarcoma cohorts.
Background Current evidence regarding gender difference in retroperitoneal liposarcoma (RLPS) is scarce, so we sought to investigate whether gender may affect prognosis after primary resection of RLPS. Methods We used the Surveillance, Epidemiology, and End Results (SEER) database to identify RLPS patients from January 1973 to December 2015. Multivariate cox proportional hazard analysis was adopted to generate adjusted hazard ratio (AHR) and 95% confidence intervals (CIs) of survival outcomes. Results In total, 2108 RLPS patients, including 971 women and 1137 men, were identified, with a median follow-up of 45.0 (17.0-92.0) months. The 5-year and 10-year overall survival rates were 50.5% and 31.5% for men and 60.4% and 42.5% for women. The 5-year and 10-year disease-specific survival rates for men and women were 71.5%, 57.3% and 76.3%, 62.1%, respectively. We found men were associated with an increased risk of all-cause mortality (AHR 1.3, 95% CI 1.0-1.6, P = .017) but not disease-specific mortality (AHR 1.2, 95% CI .9-1.6, P = .246). The subgroup analyses revealed that men were associated with an increased risk of all-cause mortality in patients with low-grade tumors (AHR 1.8, 95% CI 1.3-2.5) or patients who received non-radical resection (AHR 1.6, 95% CI 1.2-2.1). In the subgroup of low-grade tumors, men were also associated with an increased risk of disease-specific mortality (AHR 2.0, 95% CI 1.2-3.3). Conclusion Men may have worse survival after primary resection of RLPS compared with women, especially in patients with low-grade tumors or patients who received non-radical resection. Gender-based disparities may deserve more attention in patients with RLPS.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2023) conducted a cohort in Retroperitoneal liposarcoma (n=2,108). Male gender vs. Female gender was evaluated on All-cause mortality (AHR 1.3, 95% CI 1.0-1.6, p=0.017). Male gender was associated with an increased risk of all-cause mortality after primary resection of retroperitoneal liposarcoma compared with female gender (AHR 1.3; 95% CI 1.0-1.6; P=0.017).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: